Author: The Carcinoid Cancer Foundation (CCF)

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

Breaking News: FDA Approves Treatment for pNET Patients

For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients!  The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients.  This is a milestone for the carcinoid/NET…

All Things Zebra for Carcinoid and Neuroendocrine Tumor Awareness

At the Carcinoid Cancer Foundation we get many inquiries about where to purchase zebra-striped pins and other awareness items.  We have scoured the Internet to share a wide variety of jewelry, party supplies, note cards, luggage, organizers, and everyday…

Carcinoid Cancer Foundation Thanks Symposium Sponsors

There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual  symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City.  The Foundation…

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

Multiple Endocrine Neoplasia (MEN) Seminar Scheduled for September 2011 at Mayo Clinic

SPECIAL NOTE:  This seminar has been cancelled but may be rescheduled at a later date in a different format.  We will post any updates we  receive.

__________________________________________________________________

MEN, carcinoid, and neuroendocrine…

CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals

Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…

Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting

Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …

Carcinoid Patient’s Stepdaughter Runs in Sun Trust National Marathon in Support of Carcinoid Cancer Foundation

If you are in Washington, D.C. on Saturday, March 26th cheer on Alex Todd-Lippock, bib number 3029, when she runs in the 2011 Sun Trust National Marathon in support of the Carcinoid Cancer Foundation (CCF). Ms. Todd-Lippock’s stepmother, Lisa Todd, is…

RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients

Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund.  According to Ebrahim…